224 related articles for article (PubMed ID: 22276636)
1. Interactions of amylinergic and melanocortinergic systems in the control of food intake and body weight in rodents.
Roth JD; D'Souza L; Griffin PS; Athanacio J; Trevaskis JL; Nazarbaghi R; Jodka C; Athanacio J; Hoyt J; Forood B; Parkes DG
Diabetes Obes Metab; 2012 Jul; 14(7):608-15. PubMed ID: 22276636
[TBL] [Abstract][Full Text] [Related]
2. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
Roth JD; Trevaskis JL; Wilson J; Lei C; Athanacio J; Mack C; Kesty NC; Coffey T; Weyer C; Parkes DG
Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
[TBL] [Abstract][Full Text] [Related]
3. Effects of amylin and bupropion/naltrexone on food intake and body weight are interactive in rodent models.
Clapper JR; Athanacio J; Wittmer C; Griffin PS; D'Souza L; Parkes DG; Roth JD
Eur J Pharmacol; 2013 Jan; 698(1-3):292-8. PubMed ID: 23178527
[TBL] [Abstract][Full Text] [Related]
4. Combination therapy with amylin and peptide YY[3-36] in obese rodents: anorexigenic synergy and weight loss additivity.
Roth JD; Coffey T; Jodka CM; Maier H; Athanacio JR; Mack CM; Weyer C; Parkes DG
Endocrinology; 2007 Dec; 148(12):6054-61. PubMed ID: 17761760
[TBL] [Abstract][Full Text] [Related]
5. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
Trevaskis JL; Lei C; Koda JE; Weyer C; Parkes DG; Roth JD
Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
[TBL] [Abstract][Full Text] [Related]
6. Influence of high-fat feeding, diet-induced obesity, and hyperamylinemia on the sensitivity to acute amylin.
Boyle CN; Rossier MM; Lutz TA
Physiol Behav; 2011 Jul; 104(1):20-8. PubMed ID: 21550355
[TBL] [Abstract][Full Text] [Related]
7. Amylin improves the effect of leptin on insulin sensitivity in leptin-resistant diet-induced obese mice.
Kusakabe T; Ebihara K; Sakai T; Miyamoto L; Aotani D; Yamamoto Y; Yamamoto-Kataoka S; Aizawa-Abe M; Fujikura J; Hosoda K; Nakao K
Am J Physiol Endocrinol Metab; 2012 Apr; 302(8):E924-31. PubMed ID: 22275759
[TBL] [Abstract][Full Text] [Related]
8. Multi-hormonal weight loss combinations in diet-induced obese rats: therapeutic potential of cholecystokinin?
Trevaskis JL; Turek VF; Griffin PS; Wittmer C; Parkes DG; Roth JD
Physiol Behav; 2010 May; 100(2):187-95. PubMed ID: 20206194
[TBL] [Abstract][Full Text] [Related]
9. Synergistic metabolic benefits of an exenatide analogue and cholecystokinin in diet-induced obese and leptin-deficient rodents.
Trevaskis JL; Sun C; Athanacio J; D'Souza L; Samant M; Tatarkiewicz K; Griffin PS; Wittmer C; Wang Y; Teng CH; Forood B; Parkes DG; Roth JD
Diabetes Obes Metab; 2015 Jan; 17(1):61-73. PubMed ID: 25204356
[TBL] [Abstract][Full Text] [Related]
10. Amylin-mediated restoration of leptin responsiveness in diet-induced obesity: magnitude and mechanisms.
Trevaskis JL; Coffey T; Cole R; Lei C; Wittmer C; Walsh B; Weyer C; Koda J; Baron AD; Parkes DG; Roth JD
Endocrinology; 2008 Nov; 149(11):5679-87. PubMed ID: 18669592
[TBL] [Abstract][Full Text] [Related]
11. Antiobesity action of peripheral exenatide (exendin-4) in rodents: effects on food intake, body weight, metabolic status and side-effect measures.
Mack CM; Moore CX; Jodka CM; Bhavsar S; Wilson JK; Hoyt JA; Roan JL; Vu C; Laugero KD; Parkes DG; Young AA
Int J Obes (Lond); 2006 Sep; 30(9):1332-40. PubMed ID: 16534527
[TBL] [Abstract][Full Text] [Related]
12. Antiobesity effects of the beta-cell hormone amylin in diet-induced obese rats: effects on food intake, body weight, composition, energy expenditure, and gene expression.
Roth JD; Hughes H; Kendall E; Baron AD; Anderson CM
Endocrinology; 2006 Dec; 147(12):5855-64. PubMed ID: 16935845
[TBL] [Abstract][Full Text] [Related]
13. Amylinergic control of food intake in lean and obese rodents.
Boyle CN; Lutz TA
Physiol Behav; 2011 Nov; 105(1):129-37. PubMed ID: 21324327
[TBL] [Abstract][Full Text] [Related]
14. Comparison of independent and combined chronic anti-obese effects of NPY Y2 receptor agonist, PYY(3-36), and NPY Y5 receptor antagonist in diet-induced obese mice.
Moriya R; Mashiko S; Ishihara A; Takahashi T; Murai T; Ito J; Mitobe Y; Oda Z; Iwaasa H; Takehiro F; Kanatani A
Peptides; 2009 Jul; 30(7):1318-22. PubMed ID: 19394383
[TBL] [Abstract][Full Text] [Related]
15. Amylinergic control of food intake.
Lutz TA
Physiol Behav; 2006 Nov; 89(4):465-71. PubMed ID: 16697020
[TBL] [Abstract][Full Text] [Related]
16. Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats.
Roth JD; Hughes H; Coffey T; Maier H; Trevaskis JL; Anderson CM
Am J Physiol Endocrinol Metab; 2007 Oct; 293(4):E1112-7. PubMed ID: 17698985
[TBL] [Abstract][Full Text] [Related]
17. [D-Leu-4]-OB3, a synthetic peptide amide with leptin-like activity, augments the effects of orally delivered exenatide and pramlintide acetate on energy balance and glycemic control in insulin-resistant male C57BLK/6-m db/db mice.
Leinung MC; Grasso P
Regul Pept; 2012 Nov; 179(1-3):33-8. PubMed ID: 22960403
[TBL] [Abstract][Full Text] [Related]
18. [The study on mechanism of appetite regulation in diet-induced obesity resistant rats].
Liu R; Sun CH; Weng Y
Zhonghua Yu Fang Yi Xue Za Zhi; 2005 Mar; 39(2):119-21. PubMed ID: 15842834
[TBL] [Abstract][Full Text] [Related]
19. Amylin and GLP-1 target different populations of area postrema neurons that are both modulated by nutrient stimuli.
Züger D; Forster K; Lutz TA; Riediger T
Physiol Behav; 2013 Mar; 112-113():61-9. PubMed ID: 23438370
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of amylin/leptin synergy in rodent models.
Turek VF; Trevaskis JL; Levin BE; Dunn-Meynell AA; Irani B; Gu G; Wittmer C; Griffin PS; Vu C; Parkes DG; Roth JD
Endocrinology; 2010 Jan; 151(1):143-52. PubMed ID: 19875640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
